dorsaVi Reports Growth and Innovation in Q4
Company Announcements

dorsaVi Reports Growth and Innovation in Q4

dorsaVi Limited (AU:DVL) has released an update.

dorsaVi Limited reported a 10% increase in Q4 sales revenue to $363k, with an annualized recurring revenue of $1.1m, signaling consistent growth. The company also completed a pivotal data agreement with Norton Healthcare, advancing its presence in the US healthcare market. Additionally, dorsaVi launched innovative AI-based features for their wearable sensor technology, aimed at broadening their reach in different healthcare sectors.

For further insights into AU:DVL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!